Ensure a worry-free journey with our Atovaquone/Proguanil 250mg/100mg tablets designed exclusively for adults traveling to Malaria-endemic areas. We prioritise your health and safety, offering a convenient and effective solution for Malaria prevention.
Comprehensive Protection for Varied Durations:
- 1-7 Days (16 Tablets):
- Take 2 days prior to your trip.
- One tablet daily during the entire duration of your trip.
- Continue with one tablet daily for 28 days after your return.
- 8-14 Days (23 Tablets):
- Administer 2 days before your trip.
- Take one tablet daily throughout your travel period.
- Maintain the regimen with one tablet daily for 28 days post-travel.
- 15-21 Days (30 Tablets):
- Begin 2 days before your trip.
- One tablet daily for the entire duration of your travel.
- Sustain the routine with one tablet daily for 28 days after returning.
- 22-28 Days (37 Tablets):
- Commence the medication 2 days prior to your trip.
- Daily dosage during the trip.
- Post-travel, continue with one tablet daily for 28 days.
- 29-42 Days (51 Tablets):
- Take 2 days before your trip.
- Daily administration during the entire travel period.
- Follow up with one tablet daily for 28 days after returning.
- 43-56 Days (65 Tablets):
- Start 2 days before your trip.
- Consistent daily dosage during your travels.
- Post-travel, continue with one tablet daily for 28 days.
- 57-70 Days (79 Tablets):
- Initiate the medication 2 days prior to your trip.
- Daily dosage throughout the travel period.
- Sustain the regimen with one tablet daily for 28 days after returning.
- 71-84 Days (93 Tablets):
- Administer 2 days before your trip.
- One tablet daily during your travel.
- Continue with one tablet daily for 28 days after your return.
Our Atovaquone/Proguanil tablets are your reliable companion for Malaria prevention. Prioritise your well-being and travel confidently with our tailored medication plans. Trust Doctor In My Pocket-UK for 24/7 medical support, ensuring your health remains our top priority.
Reviews
There are no reviews yet.